CEL-SCI Corporation Stock News

CEL-SCI (NYSEMKT: CVM ) stock is dropping on Tuesday after the biotechnology company announced details of a public share offering. CEL-SCI is offering up 2.5 million shares of its common stock at a p

Morgan Stanley cut Tesla, Inc. (NASDAQ: TSLA) price target from $330 to $250. Morgan Stanley analyst Adam Jonas maintained an Overweight rating on the stock. Tesla shares rose 4.4% to $117.65 in p

Gainers Zovio Inc (NASDAQ: ZVO) rose 39.5% to $0.2449 in pre-market trading after gaining 7% on Thursday. HeartCore Enterprises, Inc. (NASDAQ: HTCR) shares rose 14.5% to $1.73 in pre-market trading.

CEL-SCI demonstrated significant clinical benefits for head & neck cancer patients. In the lower-risk group, there was a 14.1% absolute survival improvement.

Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 115.7% to close at $17.73 on volatility following the company's IPO earlier this month. Liberty TripAdvisor Holdings, Inc. (NASDAQ: LT

Gainers United Maritime Corporation (NASDAQ: USEA) shares climbed 175.9% to close at $6.07 on Friday. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offer

Gainers United Maritime Corporation (NASDAQ: USEA) shares jumped 180.9% to $6.19. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering on Wednesday. Ce

Should you invest in penny stocks right now? The post The Best Stocks To Invest In Right Now? 3 Penny Stocks To Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.c

Are these high-volume penny stocks on your buy list right now? The post 3 Penny Stocks to Watch With Above Average Volume Today  appeared first on Penny Stocks to Buy, Picks, News and Information | P

Are these high-volume penny stocks on your buy list right now? The post 3 Penny Stocks to Watch With Above Average Volume Today  appeared first on Penny Stocks to Buy, Picks, News and Information | P

Upgrades According to Wolfe Research, the prior rating for Cullen/Frost Bankers Inc (NYSE:CFR) was changed from Underperform to Outperform. For the fourth quarter, Cullen/Frost Bankers had an EPS of $

Cel-Sci press release (CVM): FQ1 GAAP EPS of -$0.20.As of December 31, 2021, the company had $37.1M in cash and cash equivalents."Our current focus is in three primary areas, all of…

CEL-SCI Corporation (CVM) shares closed today at 0.3% above its 52 week low of $6.08, giving the company a market cap of $263M. The stock is currently down 14.1% year-to-date, down 53.8% over the past 12 months, and up 92.1% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 0.7%. Trading Activity Trading volume this week was 35.4% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.1. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -2275.4% The company's stock price performance over the past 12 months lags the peer average by 181.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

CEL-SCI Corporation (CVM) shares closed today at 1.0% above its 52 week low of $6.10, giving the company a market cap of $279M. The stock is currently down 8.9% year-to-date, down 51.4% over the past 12 months, and up 72.5% over the past five years. This week, the Dow Jones Industrial Average fell 1.4%, and the S&P 500 fell 1.6%. Trading Activity Trading volume this week was 68.9% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.1. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -387.6% The company's stock price performance over the past 12 months lags the peer average by 205.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.